Search:

Search for text in:

separate each search
term with a space

Multiple terms:

Additional Search Filters:

clear all | select all

Conference Years:

clear all | select all

Days Within Meeting:

clear all | select all

Conferences:

Availability:

clear all | select all

Participation Type:

clear all | select all

Topic Tracks*:

clear all | select all

Organ Site Tracks*:

Showing session: reset

Plenary Session 1: Cellular Immunotherapy

  • Sort by:
  • Browse by:
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4
Plenary Session 1: Cellular Immunotherapy
Mutation-driven drug development (targeted agents) vs. immunotherapeutics development
Alexander M Eggermont
Gustave Roussy Cancer Institute, Villejuif, Paris-Sud, France
from 2015 Molecular Targets and Cancer Therapeutics conference on November 6, 2015 10:00 AM-12:00 PM
Plenary Session 1: Cellular Immunotherapy
CAR therapy for cancer: Emerging insights
Crystal L. Mackall
National Cancer Institute, Bethesda, MD, United States
from 2015 Molecular Targets and Cancer Therapeutics conference on November 6, 2015 10:00 AM-12:00 PM
Plenary Session 1: Cellular Immunotherapy
TIL therapy in the era of immune checkpoint blockade
John B.A.G. Haanen
Netherlands Cancer Inst., Amsterdam, Netherlands
from 2015 Molecular Targets and Cancer Therapeutics conference on November 6, 2015 10:00 AM-12:00 PM
Plenary Session 1: Cellular Immunotherapy
Engineering T cells with introduced TCRs to effectively target tumors
Philip D Greenberg
Fred Hutchinson Cancer Res. Ctr. & Univ. of Washington, Seattle, WA, United States
from 2015 Molecular Targets and Cancer Therapeutics conference on November 6, 2015 10:00 AM-12:00 PM
<< first | < prev page: of 1 records per page: next > | last >>
pages: 1 presentations: 1 to 4 of 4